Waverley Pharma Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was CAD 543,389 compared to CAD 257,195 a year ago. Net loss was CAD 147,355 compared to CAD 202,066 a year ago. For the half year, sales was CAD 903,352 compared to CAD 596,216 a year ago. Net loss was CAD 321,225 compared to CAD 384,598 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.